Bio Place

Latest Medical, Biological, and Genomic News!


Asthma drug Dupixent provides 30% reduction in exacerbations of COPD

"In a late stage trial Dupixent, jointly developed with Regeneron...led to a 30% reduction in moderate or severe acute exacerbations of chronic obstructive pulmonary disease (COPD), a potentially deadly disease."
2023-03-23 05:40:50